keyboard_arrow_up

Multiplex Assays Market worth 3.76 Billion USD by 2021

The report "Multiplex Assays Market Product (Consumable (Kits & Reagents, Panels), Type 9nucleic Acid-Based, Protein-Based), Technology (PCR, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021", provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the multiplex assays market along with the estimates and forecasts of the revenue.

 

Browse 111 market data Tables and 59 Figures spread through 173 Pages and in-depth TOC on "Multiplex Assays Market

 

http://www.marketsandmarkets.com/Market-Reports/multiplex-assays-market-61593314.html

 

Early buyers will receive 10% customization on this report.

The multiplex assays market is projected to reach USD 3.76 Billion by 2021 from USD 2.66 Billion in 2016, growing at a CAGR of 7.2% during the forecast period (2016–2021).

The adoption of companion diagnostics for increasing safety & efficacy of therapies, need for effective analytical platforms in research to reduce operational costs, advantages of multiplexing over traditional assays are the major drivers for the multiplex assays market. Increasing validation of biomarkers in molecular and protein diagnostics are expected to further drive the growth of the multiplex assays market. However, high cost of multiplex assay instruments will restrain the growth of this market.

The multiplex assays market is broadly segmented into products & services, type, technology, applications, end users and regions. The products & services segment is further segmented into consumables, instruments, accessories, and software and services. The consumables subsegment is expected to account for the largest share of the products & services segment in 2016, owing to increasing demand for consumables.

Talk to Our Research Analysts for More Info@

http://www.marketsandmarkets.com/speaktoanalyst.asp?id=61593314

On the basis of type, the multiplex assays market is categorized into nucleic acid-based assays and protein-based assays. Nucleic acid-based assays segment is further classified into planar nucleic acid assays and bead-based nucleic acid assays.. Protein-based assays segment is further categorized into planar protein assays and bead-based protein assays. The protein based assays segment is expected to be the fastest growing segment of the multiplex assays market in during the forecast period due to adoption of these assays in research purpose.

Factors such as need for effective analytical platforms in research to reduce operational costs are driving the growth of this segment.

The technology segment of the multiplex assays market is categorized into multiplex polymerase chain reaction, multiplex arrays, and other technologies. The multiplex arrays segment is further divided into planar arrays and bead-based arrays. The multiplex arrays segment is expected to account for the largest share of the multiplex assays market in 2016. The advantages of multiplexing over traditional assays, need for effective analytical platforms in research to reduce operational costs, and adoption of companion diagnostics for increasing safety & efficacy of therapy by multiplex assays are driving the growth of this segment.

Get The Sample Copy Of This Report:

http://www.marketsandmarkets.com/requestsample.asp?id=61593314

The applications segment of the multiplex assays market is categorized into research & development, diseases & disorders, companion diagnostics, and other applications. The research & development segment is expected to account for the largest share of the multiplex assays market in 2016. Factors such as convenience in performing the assays and faster results offered by multiplex assays are driving the growth of this segment.

On the basis of end user, the multiplex assays market is segmented into academic and research institutes, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, and other end users. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share in 2016 due to increased adoption of multiplex assays in this segment.

Major players in the multiplex assays market include Luminex Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and QIAGEN N.V. (Netherlands).

Browse Related Reports:

Molecular Diagnostics Market by Application (Infectious Disease (HIV, HPV, TB), Oncology, Genetics, Microbiology), Technology (PCR, Microarray, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Software) - Forecast to 2020

http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

 Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019

http://www.marketsandmarkets.com/Market-Reports/immunoassay-market-436.html

 

About MarketsandMarkets:

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

 

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

 

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

 

Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Subscription.html

 

Contact:
Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology

Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets